Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
Tweet Send to a Friend
(Updated - October 5, 2026 10:05 AM EDT)
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $400.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $400.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




